➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Aspartame

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Aspartame?

Aspartame is an investigational drug.

There have been 5 clinical trials for Aspartame. The most recent clinical trial was a Phase 2 trial, which was initiated on March 8th 2019.

The most common disease conditions in clinical trials are Diabetes Mellitus, Obesity, Abdominal, and Kidney Diseases. The leading clinical trial sponsors are University of Toronto, Universal Integrated Corp., and Singapore General Hospital.

There are two US patents protecting this investigational drug and thirty-five international patents.

Recent Clinical Trials for Aspartame
Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to ColonoscopyUniversal Integrated Corp.Phase 3
Effects of Fenofibrate Therapy in Diabetic NephropathyNational Medical Research Council (NMRC), SingaporePhase 3
Effects of Fenofibrate Therapy in Diabetic NephropathySingapore General HospitalPhase 3

See all Aspartame clinical trials

Clinical Trial Summary for Aspartame

Top disease conditions for Aspartame
Top clinical trial sponsors for Aspartame

See all Aspartame clinical trials

US Patents for Aspartame

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Aspartame   Start Trial Halogen-substituted heterocyclic compound UBE INDUSTRIES, LTD. (Ube-Shi, JP)   Start Trial
Aspartame   Start Trial Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus Seattle Genetics, Inc. (Bothell, WA)   Start Trial
Aspartame   Start Trial Granulation of a stevia sweetener PureCircle Sdn Bhd (Kuala Lumpur, MY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.